AgeX Therapeutics Inc. (AGE) Appoints Joanne Hackett as Board Chair
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Dr. Joanne Hackett has been appointed Chairperson of AgeX’s Board of Directors. Dr. Hackett joined the Board of Directors in December 2021. She will serve in a non-executive capacity as AgeX’s Chairperson. Dr. Greg Bailey, who served as AgeX’s Chairperson since 2018, will continue to serve as a member of AgeX’s Board of Directors.
Dr. Hackett is the Head of Genomic and Precision Medicine at IQVIA, a world leader in using data, technology, advanced analytics, and expertise to help customers drive healthcare forward. From 2017 to 2020, Dr. Hackett served as Chief Commercial Officer of Genomics England, owned by the Department of Health and Social Care in the United Kingdom. During 2016 and 2017, Dr. Hackett served as Chief Commercial Officer and Interim Chief Executive Officer of the Precision Medicine Catapult, which was established in the United Kingdom with the goal of developing and commercializing precision medicine. Dr. Hackett holds a PhD in Molecular Genetics from the University of New Brunswick.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Wells Fargo (WFC) statement on stress test results, to increase third quarter common stock dividend to $0.30 per share
- Lockheed Martin (LMT) Announces US Army Order for 120 Sikorsky H-60M Black Hawks
- Core Scientific (CORZ) to Join Russell 3000 Index
Create E-mail Alert Related CategoriesBoard Changes, Corporate News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!